Title of article
Prolonged Survival of a Patient With Pelvic Recurrence of Ovarian Malignant Mixed Mullerian Tumor After Chemoradiotherapy
Author/Authors
Homaei Shandiz, Fatemeh Research Center of Solid Tumor Treatment - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Kadkhodayan, Sima Research Center of Women’s Health - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Hsanzade Mofrad, Malihe Research Center of Women’s Health - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Yousefi Roodsari, Zohre Research Center of Women’s Health - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Sharifi Sistani, Noorieh Research Center of Solid Tumor Treatment - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Nabizadeh Marvast, Majid Mashhad University of Medical Sciences, Mashhad, IR Iran , Sadeghei, Mahbobe Research Center of Solid Tumor Treatment - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran
Pages
4
From page
1
To page
4
Abstract
Introduction: Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1% of all ovarian cancers.
Case Presentation: We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. After 25 months of being disease free, she had a pelvic recurrence and a good response to chemoradiotherapy.
Conclusions: Optimal cytoreductive surgery and chemotherapy may be the best treatment in MMMT but more discussion and experiences are needed regarding the effectiveness of radiotherapy.
Keywords
Mixed Tumor , Mullerian , Cytoreductive Surgery , Chemoradiotherapy , Chemotherapy , Ovary
Journal title
Astroparticle Physics
Serial Year
2014
Record number
2420597
Link To Document